Literature DB >> 21135172

CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Sarah E Weber1, Haijun Tian, Liise-anne Pirofski.   

Abstract

Despite the success of the pneumococcal conjugate vaccine, pneumococcal pneumonia remains a significant clinical problem, and there is still much to learn about natural resistance and cellular immunity to pneumococcus. We investigated the role of T lymphocytes in resistance to serotype (ST) 3 Streptococcus pneumoniae in an intranasal infection model in C57BL/6 (wild-type [Wt]) and CD8(+) (CD8(-/-))- and CD4(+) (MHC class II(-/-))-deficient mice. CD8(-/-) mice exhibited significantly more bacterial dissemination and lung inflammation and a significantly more lethal phenotype than Wt mice. However, there was no difference in the bacterial dissemination, lung inflammation, or survival of Wt and MHC class II(-/-) mice. Perforin (Pfn)(-/-) and IFN-γ(-/-) mice, which were used to dissect the role of CD8(+) T cells in our model, also exhibited a more lethal survival phenotype than Wt mice. Comparison of lung chemokine/cytokine levels by Luminex and cellular recruitment by FACS in Wt mice and knockout strains revealed that CD8(-/-) and IFN-γ(-/-) mice, which had the most lethal survival phenotype, had more CD4(+)IL-17(+) T (Th17) cells, IL-17, neutrophil chemoattractants, and lung neutrophils, and fewer regulatory T cells than Wt mice. CD4(+) T cell depletion improved the survival of ST-infected CD8(-/-) mice, and survival studies in Th17-deficient mice revealed that the Th17 response was dispensable for ST3 resistance in our model. Taken together, these findings demonstrate that CD8(+) cells are required, but CD4(+) T cells are dispensable for resistance to ST3 pneumonia in mice and suggest a previously unsuspected role for CD8(+) cells in modulating the inflammatory response to ST3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135172      PMCID: PMC3011188          DOI: 10.4049/jimmunol.1001963

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Authors:  Richard Malley; Krzysztof Trzcinski; Amit Srivastava; Claudette M Thompson; Porter W Anderson; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 2.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

3.  Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts.

Authors:  Alison R Kerr; Lea Ann S Kirkham; Aras Kadioglu; Peter W Andrew; Paul Garside; Hal Thompson; Tim J Mitchell
Journal:  Microbes Infect       Date:  2005-04-15       Impact factor: 2.700

4.  Resident CD8+ T cells suppress CD4+ T cell-dependent late allergic airway responses.

Authors:  Susumu Isogai; Sean Jedrzkiewicz; Rame Taha; Qutayba Hamid; James G Martin
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

5.  IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance.

Authors:  Teresa Zelante; Antonella De Luca; Pierluigi Bonifazi; Claudia Montagnoli; Silvia Bozza; Silvia Moretti; Maria L Belladonna; Carmine Vacca; Carmela Conte; Paolo Mosci; Francesco Bistoni; Paolo Puccetti; Robert A Kastelein; Manfred Kopf; Luigina Romani
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

6.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

7.  Regulatory role of B cells in a murine model of allergic airway disease.

Authors:  Anurag Singh; William F Carson; Eric R Secor; Linda A Guernsey; Richard A Flavell; Robert B Clark; Roger S Thrall; Craig M Schramm
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation.

Authors:  Mark C Dessing; Marcel Schouten; Christian Draing; Marcel Levi; Sonja von Aulock; Tom van der Poll
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

9.  Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Authors:  W C Albrich; W Baughman; B Schmotzer; M M Farley
Journal:  Clin Infect Dis       Date:  2007-05-08       Impact factor: 9.079

10.  Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.

Authors:  Alan Basset; Claudette M Thompson; Susan K Hollingshead; David E Briles; Edwin W Ades; Marc Lipsitch; Richard Malley
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

View more
  44 in total

Review 1.  Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing.

Authors:  J D Aberdein; J Cole; M A Bewley; H M Marriott; D H Dockrell
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

2.  Activation-dependent modulation of Streptococcus pneumoniae-mediated death in human lymphocytes.

Authors:  Kristina M Grayson; Lance K Blevins; Melissa B Oliver; David A Ornelles; W Edward Swords; Martha A Alexander-Miller
Journal:  Pathog Dis       Date:  2017-03-01       Impact factor: 3.166

3.  Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae.

Authors:  Hernán F Peñaloza; Pamela A Nieto; Natalia Muñoz-Durango; Francisco J Salazar-Echegarai; Javiera Torres; María J Parga; Manuel Alvarez-Lobos; Claudia A Riedel; Alexis M Kalergis; Susan M Bueno
Journal:  Immunology       Date:  2015-09       Impact factor: 7.397

Review 4.  Role of MAIT cells in pulmonary bacterial infection.

Authors:  Nadine Hartmann; Melanie J Harriff; Curtis P McMurtrey; William H Hildebrand; David M Lewinsohn; Mitchell Kronenberg
Journal:  Mol Immunol       Date:  2018-06-26       Impact factor: 4.407

5.  The antiasthma effect of neonatal BCG vaccination does not depend on the Th17/Th1 but IL-17/IFN-γ balance in a BALB/c mouse asthma model.

Authors:  Yu Deng; Weichao Chen; Na Zang; Siming Li; Yan Luo; Ke Ni; Lijia Wang; Xiaohong Xie; Wei Liu; Xiqiang Yang; Zhou Fu; Enmei Liu
Journal:  J Clin Immunol       Date:  2011-02-22       Impact factor: 8.317

6.  Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias.

Authors:  J Robert Coleman; Dimitris Papamichail; Masahide Yano; María Del Mar García-Suárez; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2011-02-21       Impact factor: 5.226

7.  The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.

Authors:  Beza Seyoum; Masahide Yano; Liise-anne Pirofski
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

Review 8.  Assessing Animal Models of Bacterial Pneumonia Used in Investigational New Drug Applications for the Treatment of Bacterial Pneumonia.

Authors:  Ursula Waack; Edward A Weinstein; John J Farley
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

9.  B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.

Authors:  Jun Sik Lee; Lisa Scandiuzzi; Anjana Ray; Joyce Wei; Kimberly A Hofmeyer; Yael M Abadi; P'ng Loke; Juan Lin; Jianda Yuan; David V Serreze; James P Allison; Xingxing Zang
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

10.  Immune response to Streptococcus pneumoniae in asthma patients: comparison between stable situation and exacerbation.

Authors:  C Otero; R D Paz; N Galassi; L Bezrodnik; M R Finiasz; S Fink
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.